60 results
Page 3 of 3
424B5
3b7l9
12 May 20
Prospectus supplement for primary offering
12:02pm
6-K
EX-4.1
9al yuhrgw
11 May 20
VBL Therapeutics Announces $10.0 Million Registered Direct Offering
9:23am
424B5
9fiyc4
11 May 20
Prospectus supplement for primary offering
9:23am
6-K
EX-99.2
la3 086np5aungn0gptz
1 Nov 19
Current report (foreign)
4:15pm
424B5
hq0ld
17 May 19
Prospectus supplement for primary offering
5:19pm
6-K
EX-99.2
3q4li4gpukyouc hdco9
15 Oct 18
Notice of Annual General Meeting of Shareholders
8:15am
424B5
lvxonfo
27 Jun 18
Prospectus supplement for primary offering
9:30am
6-K
EX-4.1
hya1rb8j7 77i
27 Jun 18
VBL Therapeutics Announces $15.5 Million Registered Direct Offering Priced At-the-Market
9:29am
6-K
8sokpq ms7kpfr6p0a2
21 Apr 15
Current report (foreign)
12:00am
20-F
6wi xfsd61t9
25 Mar 15
Annual report (foreign)
12:00am
S-8
EX-4.4
z8xaj7moy94nnf0
3 Mar 15
Registration of securities for employees
12:00am
6-K
w8xo72 n3x77hi
6 Jan 15
Current report (foreign)
12:00am
424B4
2aaxmt6
2 Oct 14
Prospectus supplement with pricing info
12:00am
424B4
yh9paim n7lhrdol0
1 Aug 14
Prospectus supplement with pricing info
12:00am